{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:17:09Z","timestamp":1793848629788,"version":"4.6.1"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,4,29]],"date-time":"2007-04-29T00:00:00Z","timestamp":1177804800000},"content-version":"vor","delay-in-days":3680,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[1997,4]]},"abstract":"<jats:p>Studies on the epidemiology of common adverse cutaneous drug reactions have rarely been reported, since they can only be successfully conducted in clinics of internal medicine employing consultant dermatologists and having a comprehensive or intensive system of monitoring. Between 1974 and 1993, the adverse skin reactions occurring in divisions of general internal medicine of three different hospitals were monitored by a computerized comprehensive system. The \u201cdrug\u2010monitoring patient\u201d was defined as the recipient of at least one drug during hospitalization. The relationship of the skin reactions to drug causality in these patients had to be either definite (proven by re\u2010exposure) or probable (drug relation greater than that of nondrug causality). The skin reactions were classified into four diagnostic groups. Maculopapular exanthema, urticaria, and vasculitis were the three main groups. The fourth group comprised cases of nonhomogeneous but clinically well\u2010defined special exanthema. For selected drugs and years of observation, special emphasis was placed on the study of time patterns (reaction time, exposure time). A total of 1317 definite or probable drug\u2010induced skin reactions occurred during the hospitalization of 48 005 consecutively admitted \u201cdrug\u2010monitoring patients\u201d: 1201 cases of maculopapular exanthema, 78 cases of urticaria, 18 cases of cutaneous vasculitis, and 20 cases of special exanthema (five of erythema multiforme minor, six of fixed eruption, one of photosensitivity reaction, and eight of acneiform eruption). The main drugs involved did not differ for the three main types of skin reactions, penicillins ranking in the first place, followed by sulfonamides \u2010 most often combined with trimethoprim \u2010 and in the third place nonsteroidal anti\u2010inflammatory drugs. The reaction time (time from last drug exposure to first skin manifestation) for urticaria showed a relevant proportion of the acute type (within 1 h) and most of the subacute type (1\u201024 h). For maculopapular exanthema, the subacute or, rarely, the latent type (2\u20108 days, exceptionally more than 8 days) predominated. For aminopenicillins, the rate of occurrence of skin reactions increased with increasing exposure time up to 12 days, and then markedly diminished. Possibly due to the tendency to withdraw suspected drugs even in the case of minor (e.g., maculopapular) skin reactions, no severe events such as erythema multiforme major\/Stevens\u2010Johnson syndrome or toxic epidermal necrolysis occurred.<\/jats:p>","DOI":"10.1111\/j.1398-9995.1997.tb01017.x","type":"journal-article","created":{"date-parts":[[2007,5,13]],"date-time":"2007-05-13T20:24:50Z","timestamp":1179087890000},"page":"388-393","source":"Crossref","is-referenced-by-count":173,"title":["Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20\u2010year survey"],"prefix":"10.1111","volume":"52","author":[{"given":"Th.","family":"Hunziker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.\u2010P.","family":"K\u00fcnzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Braunschweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zehnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hoign\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,29]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-69088-4_6"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archderm.1990.01670250100017","article-title":"Diagnosing cutaneous adverse reactions to drugs","volume":"126","author":"Shear NH","year":"1990","journal-title":"Arch Dermatol"},{"key":"e_1_2_1_4_2","first-page":"39","volume-title":"Risk factors for adverse drug reactions","author":"Hoign\u00e9 R","year":"1990"},{"key":"e_1_2_1_5_2","unstructured":"WHO Collaborating Center for International Drug Monitoring Uppsala Sweden; edition 4th quarter 1988."},{"key":"e_1_2_1_6_2","first-page":"320","article-title":"Risikofaktoren und epidemiologische Aspekte unerw\u00fcnschter Arzneimittelwirkungen unter besonderer Ber\u00fccksichtigung der allergischen und pseudo\u2010allergischen Reaktionen","volume":"18","author":"Hoign\u00e9 R","year":"1995","journal-title":"Allergologie"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1976.03260350022021"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1001\/jama.1986.03380240052027","article-title":"Drug\u2010induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15483 consecutive inpatients, 1975 to 1982","volume":"256","author":"Bigby M","year":"1986","journal-title":"JAMA"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198705073161913"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247338"},{"key":"e_1_2_1_11_2","first-page":"1966","article-title":"Haut\u2010Nebenwirkungen unter nicht\u2010steroidalen Analgetika\u2010Entz\u00fcndungshemmern und sogenannten leichten Analgetika","volume":"117","author":"Kaiser U","year":"1987","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_1_12_2","first-page":"142","article-title":"Exantheme unter h\u00e4ufig angewandten Antibiotika und antibakteriellen Chemotherapeutika (Penicilline, speziell Aminopenicilline, Cephalosporine und Cotrimoxazol) sowie Allopurinol","volume":"116","author":"Sonntag MR","year":"1986","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.1984.03350110033025","article-title":"An expanded profile of cutaneous reactions to nonsteroidal anti\u2010inflammatory drugs","volume":"252","author":"Stern RS","year":"1984","journal-title":"JAMA"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2340\/0001555574292294","article-title":"Cutaneous reactions to drugs: a series of in\u2010patients during a five\u2010year period","volume":"74","author":"Stubb S","year":"1994","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00375796"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311906"},{"key":"e_1_2_1_17_2","first-page":"481","article-title":"R\u00e9actions cutan\u00e9es survenues au cours de la prophylaxie de masse de la m\u00e9ningite c\u00e9r\u00e9bro\u2010spinale par un sulfamide long\u2010retard","volume":"95","author":"Bergoend H","year":"1968","journal-title":"Ann Dermatol Syph"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1990.01670250043005"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1991.01680050083008"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1990.01670250049006"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(89)90020-6"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.206"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12388434"},{"key":"e_1_2_1_24_2","first-page":"1271","article-title":"Editorial: \u201cPalpable purpura\u201d","volume":"122","author":"Hoign\u00e9 R","year":"1992","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jama.1971.03190050025005","article-title":"Experience in monitoring drug reactions in outpatients: the Kaiser\u2010Permanente Drug Monitoring System","volume":"217","author":"Friedman GD","year":"1971","journal-title":"JAMA"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6268.974"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.1997.tb01017.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.1997.tb01017.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:20:38Z","timestamp":1698452438000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.1997.tb01017.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["10.1111\/j.1398-9995.1997.tb01017.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.1997.tb01017.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}